Extracorporeal membrane oxygenation for the treatment of neonatal respiratory failure.
This review discusses the use of extracorporeal membrane oxygenation (ECMO) for the treatment of respiratory failure in neonates. After briefly reviewing the early history of neonatal ECMO, the authors describe the respiratory diagnoses most often treated with ECMO and the manner in which affected neonates are deemed to have "failed" conventional therapies and thus require ECMO. After reviewing the most common indications for ECMO, factors that influence the timing of conversion to extracorporeal life support, as well as criteria that may exclude patients from receiving ECMO therapy, are described. At the conclusion of this article, the authors discuss the long-term outcomes of neonates whose respiratory disease was treated with ECMO and the costs associated with that care.
Carey
William A
WA
Division of Neonatal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA. carey.william@mayo.edu
Colby
Christopher E
CE
D015199:Extracorporeal Membrane Oxygenation / Q000191:economics / Q000379:methods*; D006801:Humans; D007231:Infant, Newborn; D018579:Patient Selection; D012131:Respiratory Insufficiency / Q000191:economics / Q000503:physiopathology / Q000628:therapy*; D017211:Treatment Failure; D016896:Treatment Outcome